Such growth makes China an increasingly important player in the global biopharmaceutical industry, offering potential market ...
With the aim to add a “revenue generating CDMO arm,” Lantheus Holdings has bought New Jersey-based radiopharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results